开云app官网登录入口网页版-官方正版

#DMARD#

30篇内容 | 1598人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1587635, encodeId=3653158e63551, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=生物制剂DMARDs治疗方案的常见临床问题, objectType=article, longId=738089, objectId=f912e3808982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f912e3808982, replyNumber=0, likeNumber=95, createdTime=2022-09-07, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f912e3808982, moduleTitle=生物制剂DMARDs治疗方案的常见临床问题, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f912e3808982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587634, encodeId=6da2158e6347d, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=ARD：使用生物 DMARD的RA患者队列中急性冠状动脉综合征的短期、中期和长期风险：来自四个北欧国家的结果, objectType=article, longId=723477, objectId=4bc3e2347798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bc3e2347798, replyNumber=0, likeNumber=77, createdTime=2022-04-06, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bc3e2347798, moduleTitle=ARD：使用生物 DMARD的RA患者队列中急性冠状动脉综合征的短期、中期和长期风险：来自四个北欧国家的结果, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4bc3e2347798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587633, encodeId=4fb2158e63367, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效, objectType=article, longId=301742, objectId=ea63301e42f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea63301e42f2, replyNumber=0, likeNumber=79, createdTime=2022-03-28, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea63301e42f2, moduleTitle=Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ea63301e42f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587632, encodeId=7a70158e632ea, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较, objectType=article, longId=299909, objectId=e2b12999097b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2b12999097b, replyNumber=0, likeNumber=90, createdTime=2022-03-03, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2b12999097b, moduleTitle=Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e2b12999097b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587631, encodeId=eda6158e631ff, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Rheumatology：巴利西替尼和托法替尼与bDMARDS治疗类风湿关节炎的疗效比较, objectType=article, longId=299676, objectId=75a62996e6e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75a62996e6e1, replyNumber=0, likeNumber=48, createdTime=2022-02-27, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75a62996e6e1, moduleTitle=Rheumatology：巴利西替尼和托法替尼与bDMARDS治疗类风湿关节炎的疗效比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=75a62996e6e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587630, encodeId=b748158e63026, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：炎症性关节病和DMARD治疗患者的流感结局, objectType=article, longId=221077, objectId=f7942210e71b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7942210e71b, replyNumber=0, likeNumber=76, createdTime=2021-11-27, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7942210e71b, moduleTitle=Ann Rheum Dis：炎症性关节病和DMARD治疗患者的流感结局, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f7942210e71b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587629, encodeId=f6f2158e62924, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎患者激素联合csDMARD 治疗后激素的减量轨迹, objectType=article, longId=215588, objectId=4c7e21558845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c7e21558845, replyNumber=0, likeNumber=66, createdTime=2021-08-13, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c7e21558845, moduleTitle=Ann Rheum Dis：类风湿性关节炎患者激素联合csDMARD 治疗后激素的减量轨迹, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4c7e21558845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587628, encodeId=cbdf158e628a6, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Semin Arthritis Rheu：tDMARDs治疗的风湿病患者COVID-19的发病率, objectType=article, longId=194466, objectId=820119446689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=820119446689, replyNumber=0, likeNumber=75, createdTime=2020-05-22, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=820119446689, moduleTitle=Semin Arthritis Rheu：tDMARDs治疗的风湿病患者COVID-19的发病率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=820119446689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587627, encodeId=667f158e62720, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：阿达木单抗血清水平和抗体对下一种bDMARD的治疗反应没有预测价值, objectType=article, longId=192894, objectId=b43119289448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b43119289448, replyNumber=0, likeNumber=88, createdTime=2020-04-26, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b43119289448, moduleTitle=Ann Rheum Dis：阿达木单抗血清水平和抗体对下一种bDMARD的治疗反应没有预测价值, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b43119289448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587626, encodeId=e96a158e626e7, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=2020 香港共识声明：生物类改善病情的抗风湿药(DMARDs)治疗多关节型JIA、附着点炎相关关节炎和银屑病关节炎, objectType=article, longId=189059, objectId=393618905962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=393618905962, replyNumber=0, likeNumber=51, createdTime=2020-03-02, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=393618905962, moduleTitle=2020 香港共识声明：生物类改善病情的抗风湿药(DMARDs)治疗多关节型JIA、附着点炎相关关节炎和银屑病关节炎, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=393618905962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587625, encodeId=9fa0158e62547, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=J Rheumatol：类风湿性关节炎b/tsDMARD停药和坚持二线治疗的原因, objectType=article, longId=184790, objectId=3498184e9022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3498184e9022, replyNumber=0, likeNumber=70, createdTime=2019-12-17, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3498184e9022, moduleTitle=J Rheumatol：类风湿性关节炎b/tsDMARD停药和坚持二线治疗的原因, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3498184e9022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587624, encodeId=c63f158e6243e, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响, objectType=article, longId=178120, objectId=f7071e8120be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7071e8120be, replyNumber=0, likeNumber=69, createdTime=2019-08-24, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7071e8120be, moduleTitle=Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f7071e8120be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587623, encodeId=6e33158e62378, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较, objectType=article, longId=163822, objectId=8ea416382257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ea416382257, replyNumber=0, likeNumber=65, createdTime=2019-04-10, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ea416382257, moduleTitle=Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8ea416382257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587622, encodeId=7659158e62212, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Semin Arthritis Rheu：两种bDMARDs联合治疗类风湿性关节炎的安全性, objectType=article, longId=156410, objectId=2f321564100d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f321564100d, replyNumber=0, likeNumber=94, createdTime=2018-12-24, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f321564100d, moduleTitle=Semin Arthritis Rheu：两种bDMARDs联合治疗类风湿性关节炎的安全性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2f321564100d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587621, encodeId=6c8c158e6211f, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：世界各国bDMARD用药情况受哪些因素影响？, objectType=article, longId=154207, objectId=391d15420ed7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=391d15420ed7, replyNumber=0, likeNumber=53, createdTime=2018-11-24, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=391d15420ed7, moduleTitle=Ann Rheum Dis：世界各国bDMARD用药情况受哪些因素影响？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=391d15420ed7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587620, encodeId=d00d158e620d4, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：bDMARD应答不佳的RA患者下一步选啥药？, objectType=article, longId=151156, objectId=f33e15115608, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f33e15115608, replyNumber=0, likeNumber=125, createdTime=2018-10-18, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f33e15115608, moduleTitle=Ann Rheum Dis：bDMARD应答不佳的RA患者下一步选啥药？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f33e15115608)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587619, encodeId=f9e0158e61904, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：DMARD初治的幼年特发性关节炎中实现非活动性疾病的靶标治疗, objectType=article, longId=151077, objectId=f0021510e750, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0021510e750, replyNumber=0, likeNumber=64, createdTime=2018-10-17, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0021510e750, moduleTitle=Ann Rheum Dis：DMARD初治的幼年特发性关节炎中实现非活动性疾病的靶标治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f0021510e750)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587618, encodeId=cab9158e6183b, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Arthritis Care Res：RA患者启动或换用DMARD治疗的患者报告结局检测信息系统（PROMIS）反应性, objectType=article, longId=144163, objectId=ce5514416383, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce5514416383, replyNumber=0, likeNumber=55, createdTime=2018-07-13, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce5514416383, moduleTitle=Arthritis Care Res：RA患者启动或换用DMARD治疗的患者报告结局检测信息系统（PROMIS）反应性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ce5514416383)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587617, encodeId=8b20158e61761, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：bDMARD药物获取的不平等及其如何影响各国疾病预后：METEOR登记结果, objectType=article, longId=142773, objectId=2049142e7368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2049142e7368, replyNumber=0, likeNumber=82, createdTime=2018-07-10, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2049142e7368, moduleTitle=Ann Rheum Dis：bDMARD药物获取的不平等及其如何影响各国疾病预后：METEOR登记结果, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2049142e7368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587616, encodeId=3a0d158e616e4, content=<a href='/topic/show?id=d6706042a3' target=_blank style='color:#2F92EE;'>#DMARD#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎中的bDMARD难治性疾病, objectType=article, longId=142768, objectId=b0bf142e6880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0bf142e6880, replyNumber=0, likeNumber=70, createdTime=2018-07-10, rootId=0, userName=whlxd, userId=94e417527720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0bf142e6880, moduleTitle=Ann Rheum Dis：类风湿性关节炎中的bDMARD难治性疾病, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b0bf142e6880)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

DMARD

2020-05-29

whlxd (审核中...)

前往app查看评论内容

#DMARD#

生物制剂DMARDs治疗方案的常见临床问题

2022-09-07

whlxd (审核中...)

前往app查看评论内容

#DMARD#

ARD：使用生物 DMARD的RA患者队列中急性冠状动脉综合征的短期、中期和长期风险：来自四个北欧国家的结果

2022-04-06

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Rheumatology：Apremilast单药治疗DMARD无效的活动性银屑病关节炎的长期疗效

2022-03-28

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较

2022-03-03

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Rheumatology：巴利西替尼和托法替尼与bDMARDS治疗类风湿关节炎的疗效比较

2022-02-27

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：炎症性关节病和DMARD治疗患者的流感结局

2021-11-27

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：类风湿性关节炎患者激素联合csDMARD 治疗后激素的减量轨迹

2021-08-13

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Semin Arthritis Rheu：tDMARDs治疗的风湿病患者COVID-19的发病率

2020-05-22

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：阿达木单抗血清水平和抗体对下一种bDMARD的治疗反应没有预测价值

2020-04-26

whlxd (审核中...)

前往app查看评论内容

#DMARD#

2020 香港共识声明：生物类改善病情的抗风湿药(DMARDs)治疗多关节型JIA、附着点炎相关关节炎和银屑病关节炎

2020-03-02

whlxd (审核中...)

前往app查看评论内容

#DMARD#

J Rheumatol：类风湿性关节炎b/tsDMARD停药和坚持二线治疗的原因

2019-12-17

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：类风湿性关节炎病程和既往使用DMARDs对治疗结局的影响

2019-08-24

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：类风湿性关节炎患者疾病控制后逐渐减少TNF抑制剂与常规合成DMARDs的比较

2019-04-10

爆笑小医 (审核中...)

前往app查看评论内容

#DMARD#

Semin Arthritis Rheu：两种bDMARDs联合治疗类风湿性关节炎的安全性

2018-12-24

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：世界各国bDMARD用药情况受哪些因素影响？

2018-11-24

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：bDMARD应答不佳的RA患者下一步选啥药？

2018-10-18

docwu2019 (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：DMARD初治的幼年特发性关节炎中实现非活动性疾病的靶标治疗

2018-10-17

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Arthritis Care Res：RA患者启动或换用DMARD治疗的患者报告结局检测信息系统（PROMIS）反应性

2018-07-13

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：bDMARD药物获取的不平等及其如何影响各国疾病预后：METEOR登记结果

2018-07-10

whlxd (审核中...)

前往app查看评论内容

#DMARD#

Ann Rheum Dis：类风湿性关节炎中的bDMARD难治性疾病

2018-07-10

科室
- - 订阅+
  - 更多科室
工具
服务